Quintiles Transnational, the world’s largest pharmaceuticals services company, expects to double its business in Asia over the next five to 10 years as the region’s emerging economies experience “dramatic” growth in demand for medicines.

Dennis Gillings, chairman and chief executive of the privately held US group, said Quintiles had grown strongly through the global financial crisis because big pharmaceutical companies had stepped up efforts to cut costs by outsourcing sales and research.